Latest news
Iovance Biotherapeutics (IOVA) Stock Price Trails Record Revenue And Margin Gains - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:28:31 GMTArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 20:05:55 GMT24 New Arcutis Employees Get Stock Awards That Vest Over Four Years - Stock TitanStock Titan · Fri, 07 Aug 2026 20:00:00 GMTBlossomHill, Latigo outshine IPO expectations with oversubscribed debuts - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:10:10 GMTNorthwest Biotherapeutics announces MoU with Saudi Pharmaceutical Industries and Medical Appliance Company - BioSpectrum AsiaBioSpectrum Asia · Fri, 07 Aug 2026 13:26:04 GMTLatigo Biotherapeutics Rings the Opening Bell - NasdaqNasdaq · Fri, 07 Aug 2026 13:15:00 GMTDoes Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect? - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 13:02:14 GMTLatigo Biotherapeutics raises $345.6M in IPO - AxiosAxios · Fri, 07 Aug 2026 12:41:31 GMT